Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics: recent clinical findings from randomized trials.

Anand R, Turolla A, Chinellato G, Sansi F, Roy A, Hartman R. 

Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253251414529

The full text of the article is available on the publisher’s website at the following link:
https://journals.sagepub.com/doi/10.1177/20451253251414529

The article is published in Open Access under the Creative Commons Attribution–NonCommercial 4.0 International (CC BY-NC 4.0) license.

This reference is provided solely for informational and scientific contextualization purposes and does not constitute an endorsement, financial advice, or an investment recommendation